Antigenics awarded $424.

Competitiveness and create high quality careers in the U.S.. Antigenics awarded $424,720 grant under QTDP program Antigenics Inc. today announced that it’s been awarded $424,720 in grants under the IRS’ Qualifying Therapeutic Discovery Task system. The QTDP program was established due to the individual Protection and Affordable Care Act of 2010. Under the program, tasks were selected by the Treasury Division and the Department of Human and Wellness Services. To be able to qualify, tasks had to incur preclinical or medical research costs during 2009 or 2010 and be designed to result in one or more new therapies to take care of or prevent a disease or condition representing an unmet medical want, reduce long-term health care costs in the U.S.While we understand that we now have no genetic markers with solid effect, which means that there are plenty of genetic markers involved. Whilst every particular genetic marker may possess a small effect, they may soon add up to make a meaningful prediction, Tansey added. We’ve a very good way to go to determine genetic markers that may usefully guide the treating major depression. There are two essential challenges to this procedure, stated Dr. John Krystal, Editor of Biological Psychiatry.

Comments are closed.